Literature DB >> 7907572

Immunosuppressive and other effects of mycophenolic acid and an ester prodrug, mycophenolate mofetil.

A C Allison1, E M Eugui.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 7907572     DOI： 10.1111/j.1600-065x.1993.tb00652.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN： 0105-2896            Impact factor:   12.988


× No keyword cloud information.
  52 in total

Review 1.  Therapeutic drug monitoring of immunosuppressant drugs.

Authors:  A Johnston; D W Holt
Journal:  Br J Clin Pharmacol       Date:  1999-04       Impact factor: 4.335

2.  Inter-ethnic variability of three functional polymorphisms affecting the IMPDH2 gene.

Authors:  Anne Garat; Christian Lacks Lino Cardenas; Arnaud Lionet; Aurore Devos; François Glowacki; Abderraouf Kenani; Florence Migot-Nabias; Delphine Allorge; Jean-Marc Lo-Guidice; Franck Broly; Christelle Cauffiez
Journal:  Mol Biol Rep       Date:  2010-12-23       Impact factor: 2.316

3.  Trapped Chromatin Fibers Damage Flowing Red Blood Cells.

Authors:  Maedeh Roushan; Mehdi Jorfi; Avanish Mishra; Keith H K Wong; Julianne Jorgensen; Eric Ell; James F Markmann; Jarone Lee; Daniel Irimia
Journal:  Adv Biosyst       Date:  2018-08-12

4.  Pharmacological targeting of guanosine monophosphate synthase suppresses melanoma cell invasion and tumorigenicity.

Authors:  A Bianchi-Smiraglia; J A Wawrzyniak; A Bagati; E K Marvin; J Ackroyd; S Moparthy; W Bshara; E E Fink; C E Foley; G E Morozevich; A E Berman; D S Shewach; M A Nikiforov
Journal:  Cell Death Differ       Date:  2015-04-24       Impact factor: 15.828

Review 5.  The use of therapeutic drug monitoring to optimise immunosuppressive therapy.

Authors:  S M Tsunoda; F T Aweeka
Journal:  Clin Pharmacokinet       Date:  1996-02       Impact factor: 6.447

6.  Mycophenolate mofetil in the treatment of uveitis in children.

Authors:  D Doycheva; C Deuter; N Stuebiger; S Biester; M Zierhut
Journal:  Br J Ophthalmol       Date:  2006-07-06       Impact factor: 4.638

Review 7.  An update on the use of mycophenolate mofetil in lupus nephritis and other primary glomerular diseases.

Authors:  Alice S Appel; Gerald B Appel
Journal:  Nat Clin Pract Nephrol       Date:  2009-01-27

8.  Mycophenolate mofetil therapy for children with steroid-resistant nephrotic syndrome.

Authors:  Zhihui Li; Cuirong Duan; Jinhua He; Tianhui Wu; Mai Xun; Yi Zhang; Yan Yin
Journal:  Pediatr Nephrol       Date:  2009-12-02       Impact factor: 3.714

9.  Effect of mycophenolate mofetil on the pharmacokinetics of antiretroviral drugs and on intracellular nucleoside triphosphate pools.

Authors:  Sanjay U C Sankatsing; Patrick G Hoggard; Alwin D R Huitema; Rolf W Sparidans; Stephen Kewn; Kristel M L Crommentuyn; Joep M A Lange; Jos H Beijnen; David J Back; Jan M Prins
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

10.  Randomised trial of mycophenolate mofetil versus azathioprine for treatment of chronic active Crohn's disease.

Authors:  M F Neurath; R Wanitschke; M Peters; F Krummenauer; K H Meyer zum Büschenfelde; J F Schlaak
Journal:  Gut       Date:  1999-05       Impact factor: 23.059
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.